The latest closing stock price for Prelude Therapeutics as of June 16, 2025 is 0.97.
An investor who bought $1,000 worth of Prelude Therapeutics stock at the IPO in 2020 would have $-963 today, roughly -1 times their original investment - a -48.23% compound annual growth rate over 5 years.
The all-time high Prelude Therapeutics stock closing price was 91.68 on February 10, 2021.
The Prelude Therapeutics 52-week high stock price is 6.80, which is 601% above the current share price.
The Prelude Therapeutics 52-week low stock price is 0.61, which is 37.1% below the current share price.
The average Prelude Therapeutics stock price for the last 52 weeks is 2.06.
An investor who bought $1,000 worth of Prelude Therapeutics stock at the IPO in 2020 would have $-963 today, roughly -1 times their original investment - a -48.23% compound annual growth rate over 5 years.
The all-time high Prelude Therapeutics stock closing price was 91.68 on February 10, 2021.
The Prelude Therapeutics 52-week high stock price is 6.80, which is 601% above the current share price.
The Prelude Therapeutics 52-week low stock price is 0.61, which is 37.1% below the current share price.
The average Prelude Therapeutics stock price for the last 52 weeks is 2.06.